跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,251 条关于
“11β-HSD”
全部
5,251
临床试验
3,072
药物
1,794
机构
31
资讯
354
14年前
GIP Reduces Free Fatty Acids via 11β-HSD1 Inhibition in Adipose Tissue
去年
Actinogen's Xanamem (Emestedastat) Receives WHO Recognition and Advances in Alzheimer's Trials
去年
Swissmedic Accepts Santhera's Marketing Application for AGAMREE® in Duchenne Muscular Dystrophy
去年
Agamree Receives Positive Recommendation in Scotland and NICE Guidance in the UK for Duchenne Muscular Dystrophy
2个月前
Emestedastat Shows Late-Emerging Antidepressant Signal in Difficult-to-Treat MDD Despite Missing Cognitive Endpoint
9个月前
Actinogen Completes Enrollment in Pivotal Alzheimer's Trial with 247 Participants
去年
Santhera's Agamree Receives NICE Recommendation and China NMPA Approval for Duchenne Muscular Dystrophy Treatment
2年前
Actinogen Optimizes XanaMIA Phase 2b Alzheimer's Disease Trial Design
12个月前
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE Rollout for Duchenne Muscular Dystrophy
10个月前
AGAMREE Shows Superior Safety Profile with Comparable Efficacy to Standard Corticosteroids in Five-Year DMD Study
第 1 页,共 36 页
上一页
下一页